CLINICAL_TRIALS
trial_result
· 2018-08-28
Clinical Trial Update: Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015) [Phase 2]
Summary
Phase 2 clinical trial update for MK-1029 in persistent asthma uncontrolled with montelukast; results posted (completed in 2018).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2018-08-28